(Q56762771)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32214769%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

title

IDX-184 is a superior HCV direct-acting antiviral drug: a QSAR study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32214769%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32214769%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

author name string

Wael M Elshemey

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32214769%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

publication date

4 March 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32214769%20AND%20SRC:MED&resulttype=core&format=json

Medicinal Chemistry Research

15 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32214769%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32214769%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32214769%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

page(s)

1005-1008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32214769%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00044-016-1533-y

15 April 2020

exact match

0 references

cites work

Daclatasvir plus sofosbuvir for HCV infection: an oral combination therapy with high antiviral efficacy

1 reference

https://api.crossref.org/works/10.1007%2FS00044-016-1533-Y

From benzimidazole to indole-5-carboxamide Thumb Pocket I inhibitors of HCV NS5B polymerase. Part 1: indole C-2 SAR and discovery of diamide derivatives with nanomolar potency in cell-based subgenomic replicons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00044-016-1533-Y

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00044-016-1533-Y

Recent advances in drug discovery of benzothiadiazine and related analogs as HCV NS5B polymerase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00044-016-1533-Y

Advances in the development of new therapeutic agents targeting the NS3-4A serine protease or the NS5B RNA-dependent RNA polymerase of the hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00044-016-1533-Y

Approaching a new era for hepatitis C virus therapy: inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00044-016-1533-Y

Molecular modeling comparison of the performance of NS5b polymerase inhibitor (PSI-7977) on prevalent HCV genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00044-016-1533-Y

2′-Methylguanosine Prodrug (IDX-184), Phosphoramidate Prodrug (Sofosbuvir), Diisobutyryl Prodrug (R7128) Are Better Than Their Parent Nucleotides and Ribavirin in Hepatitis C Virus Inhibition: A Molecular Modeling Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00044-016-1533-Y

Correlation to protein conformation of Wide-angle X-ray Scatter parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00044-016-1533-Y

Current and future hepatitis C therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00044-016-1533-Y

Mixing the right hepatitis C inhibitor cocktail

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00044-016-1533-Y

Fullerene derivative as anti-HIV protease inhibitor: molecular modeling and QSAR approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00044-016-1533-Y

The novel nucleoside analog R1479 (4'-azidocytidine) is a potent inhibitor of NS5B-dependent RNA synthesis and hepatitis C virus replication in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00044-016-1533-Y

Development of novel therapies for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00044-016-1533-Y

Protease and helicase activities of hepatitis C virus genotype 4, 5, and 6 NS3-NS4A proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00044-016-1533-Y

Hepatitis C RNA-dependent RNA polymerase inhibitors: a review of structure-activity and resistance relationships; different scaffolds and mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00044-016-1533-Y

QSAR analysis and molecular docking simulation of suggested peptidomimetic NS3 protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00044-016-1533-Y

Mechanism of Activation of PSI-7851 and Its Diastereoisomer PSI-7977

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00044-016-1533-Y

The Electronic and Quantitative Structure Activity Relationship Properties of Modified Telaprevir Compounds as HCV NS3 Protease Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00044-016-1533-Y

Theoretical Study on Modified Boceprevir Compounds as NS3 Protease Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00044-016-1533-Y

Anti-HCV drugs in the pipeline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00044-016-1533-Y

10.1007/S00044-016-1533-Y

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32214769%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32214769%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

PubMed publication ID

32214769

1 reference